Ezepro

Ezepro is a high-protein, ready-to-drink oral nutritional supplement developed by Alniche Life Sciences in collaboration with Delhi Pharmaceutical Sciences and Research University (DPSRU). It is specifically formulated to meet the nutritional requirements of critically ill patients in intensive care settings. The product aims to prevent muscle wasting, enhance immune function, and promote early recovery by providing a concentrated source of proteins and essential nutrients. Ezepro is classified as a nutraceutical rather than a traditional pharmaceutical drug and is available as a 150 ml single-dose can with a coffee flavor. It was launched in 2019 as a variant of Complipro, which is tailored for chronic kidney disease patients.

Brand names

Ezepro